Drug Shortage Report for SODIUM CHLORIDE INJECTION USP
Report ID | 143310 |
Drug Identification Number | 00037842 |
Brand name | SODIUM CHLORIDE INJECTION USP |
Common or Proper name | Sodium Chloride Injection |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 9MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 50 mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-09-10 |
Actual start date | |
Estimated end date | 2021-09-24 |
Actual end date | 2021-09-27 |
Shortage status | Resolved |
Updated date | 2021-10-15 |
Company comments | This issue has been resolved. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2021-10-15 | English | Compare |
v6 | 2021-09-11 | English | Compare |
v5 | 2021-08-16 | French | Compare |
v4 | 2021-08-16 | English | Compare |
v3 | 2021-07-30 | French | Compare |
v2 | 2021-07-30 | English | Compare |
v1 | 2021-07-30 | English | Compare |
Showing 1 to 7 of 7